Stockholders' Equity

3 Months Ended

Sep. 30, 2025

Equity [Abstract]

Stockholders' Equity

STOCKHOLDERS’ EQUITY

AOCI

The following tables presents changes by component:

Three months ended September 30, 2024 and 2025
($000s)	Foreign Currency Translation Adjustment		Derivative Valuation		Defined Benefit Plan		Total
Balance, June 30, 2024	$	(7,883)	$	(235)	$	205	$	(7,913)
Foreign currency translation	1,388		—		—		1,388
Unrealized gains on cash flow hedges	—		298		—		298
Reclassifications to earnings	—		81		—		81
Balance, September 30, 2024	$	(6,495)	$	144	$	205	$	(6,146)

($000s)	Foreign Currency Translation Adjustment		Derivative Valuation		Defined Benefit Plan		Total
Balance, June 30, 2025	$	(6,769)	$	540	$	(107)	$	(6,336)
Foreign currency translation	(1,212)		—		—		(1,212)
Unrealized losses on cash flow hedges	—		(2,195)		—		(2,195)
Reclassifications to earnings	—		7		—		7
Balance, September 30, 2025	$	(7,981)	$	(1,648)	$	(107)	$	(9,736)

Share repurchase programs

The Board may authorize share repurchases of the Company’s common shares and the Company had multiple share repurchase plans during the three months ended September 30, 2025 and 2024. On May 1, 2025, the Board authorized $15 million in share repurchases which commenced on May 12, 2025 for twelve months (the "2025 Share Repurchase Program"). As of September 30, 2025, the amount available for repurchase under the 2025 Share Repurchase Program was $10.6 million.

During the three months ended September 30, 2025 and 2024, the Company repurchased 91,658 and 282,129 shares, respectively, of its common shares totaling $2.7 million, and $4.7 million respectively. All repurchases under these programs were funded with our existing cash balance.